Patient Leaflet Updated 28-Aug-2024 | ADVANZ Pharma
Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion
Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion
hydralazine hydrochloride
The name of your medicine is Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion referred to from now as Hydralazine Injection.
1. What Hydralazine injection is and what it is used for
2. What you need to know before you are given Hydralazine Injection
3. How you will be given Hydralazine Injection
4. Possible side effects
5. How to store Hydralazine Injection
6. Contents of the pack and other information
The name of your medicine is Hydralazine Injection.
The active ingredient is hydralazine hydrochloride in the form of a powder.
Hydralazine hydrochloride belongs to a group of medicines called antihypertensives.
Hydralazine Injection is used to treat adults with very high blood pressure, particularly when this condition occurs in pregnancy or in people with kidney disease.
It works by relaxing blood vessels which increases the supply of blood and oxygen to the heart.
Talk to your doctor or pharmacist or nurse before using Hydralazine Injection
Hydralazine Injection is not recommended for use in children. In rare cases Hydralazine Injection may be used with extreme caution to treat children.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
It is especially important that you tell your doctor if you are taking:
If you are going to have a general anaesthetic you should tell the doctor or dentist in charge that you are taking Hydralazine Injection.
It is advisable not to drink alcohol whilst taking Hydralazine Injection as it may affect you more than usual.
Taking Hydralazine Injection with food may decrease the amount of the medicine in your system, therefore, take it before food.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
You can drive while being treated with Hydralazine Injection but do not drive until you know how it affects you. It may make you feel dizzy or impair your reactions. If it affects you in this way, do not drive or operate any machinery.
This medicine will be given to you in hospital. Your doctor will decide when and how to treat you with this medicine. It can be given to you in one of 2 ways:
The recommended dose is 5 to 10 mg by intravenous injection, and will be repeated if necessary after 20 to 30 minutes.
Your blood pressure will be taken whilst you are receiving treatment and the dose adjusted to make sure that you have gradual fall in your blood pressure to normal levels.
Use in children
In the rare cases where rapid treatment proves indispensable in a child, Hydralazine injection should be used with extreme caution. The initial dose is 0.1-0.5 mg/kg body weight administered intravenously over 1-2 min with repeat doses every 30-90 min as required, up to a maximum daily dose of 3.5 mg/kg body weight
Symptoms of overdose include a faster or irregular heartbeat, low blood pressure, feeling sick, dizziness, and sweating. Chest pain, headache, vomiting and losing consciousness are also possible symptoms. As this medicine is given to you in hospital it is very unlikely that an overdose will happen. Should an overdose occur, the doctor will treat any symptoms that follow.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking the medicine and seek immediate medical advice if you notice the following:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from the available data)
If you feel very tired, experience unexpected bruising or bleeding, or more infections (e.g. colds and sore throats) than usual please tell your doctor. Your doctor may decide to conduct tests on your blood periodically as a result of these symptoms.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
The ampoules will be stored in the hospital and they will follow the instructions below.
Store the ampoules in the original package in order to protect from light. Store below 25°C.
Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of the month. The solution will be used as soon as it has been made up.
Each ampoule contains 20 mg of the active ingredient, hydralazine hydrochloride as a powder.
They also contain hydrochloric acid , water for injection and nitrogen (as an inactive ingredient).
Hydralazine Injection is provided as a white to yellow powder in 2 ml clear glass ampoules.
Each pack contains 5 ampoules.
This leaflet was last revised in January 2024
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK
+44 (0)208 588 9131
www.advanzpharma.com
+44 (0)208 588 9131
+44 (0)208 588 9273